- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 96,150 | 30.07.24 14:23:24 | +0,230 | +0,24% | 96,190 | 96,250 | 96,300 | 95,920 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 990,200 | 30.07.24 08:18:13 | -6,000 | -0,60% | 992,200 | 998,200 | 990,200 | 996,200 |
